Systemic administration of interleukin-12 enhances the therapeutic efficacy of dendritic cell-based tumor vaccines in mouse heptocellular carcinoma.

被引:0
|
作者
Tatsumi, T [1 ]
Miyagi, T [1 ]
Jinushi, M [1 ]
Sugimoto, Y [1 ]
Kuzushita, N [1 ]
Takehara, T [1 ]
Kanto, T [1 ]
Sasaki, Y [1 ]
Hori, M [1 ]
Hayashi, N [1 ]
机构
[1] Osaka Univ, Suita, Osaka, Japan
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
154
引用
收藏
页码:201A / 201A
页数:1
相关论文
共 35 条
  • [1] Administration of interleukin-12 enhances the therapeutic efficacy of dendritic cell-based tumor vaccines in mouse hepatocellular carcinoma
    Tatsumi, T
    Takehara, T
    Kanto, T
    Miyagi, T
    Kuzushita, N
    Sugimoto, Y
    Jinushi, M
    Kasahara, A
    Sasaki, Y
    Hori, M
    Hayashi, N
    CANCER RESEARCH, 2001, 61 (20) : 7563 - 7567
  • [2] Systemic administration of interleukin 2 enhances the therapeutic efficacy of dendritic cell-based tumor vaccines
    Shimizu, K
    Fields, RC
    Giedlin, M
    Mulé, JJ
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (05) : 2268 - 2273
  • [3] Systemic administration of interleukin-2 enhances the therapeutic efficacy of dendritic cell-based tumor vaccines
    Shimizu, K
    Fields, R
    Giedlin, M
    Mulé, JJ
    JOURNAL OF LEUKOCYTE BIOLOGY, 1998, : 89 - 89
  • [4] Anti-CD137 antibody administration enhances the efficacy of dendritic cell-based tumor vaccines
    Ito, F
    Li, Q
    Chang, AE
    FASEB JOURNAL, 2003, 17 (07): : C329 - C329
  • [5] Advances in dendritic cell-based therapeutic tumor vaccines
    Qin, Simin
    Na, Jintong
    Yang, Qun
    Tang, Jing
    Deng, Yamin
    Zhong, Liping
    MOLECULAR IMMUNOLOGY, 2025, 181 : 113 - 128
  • [6] Dendritic cell-based autologous tumor vaccines for head and neck squamous cell carcinoma
    Whiteside, Theresa L.
    Ferris, Robert L.
    Szczepanski, Miroslaw
    Tublin, Mitchell
    Kiss, Joseph
    Johnson, Rita
    Johnson, Jonas T.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2016, 38 : E494 - E501
  • [7] Antitumor immunity induced by dendritic cell-based vaccination is dependent on interferon-γ and interleukin-12
    Hiramoto, JS
    Tsung, K
    Bedolli, M
    Norton, JA
    Hirose, R
    JOURNAL OF SURGICAL RESEARCH, 2004, 116 (01) : 64 - 69
  • [8] Combined Tumor Cell-Based Vaccination and Interleukin-12 Gene Therapy Polarizes the Tumor Microenvironment in Mice
    Jarosz-Biej, Magdalena
    Smolarczyk, Ryszard
    Cichon, Tomasz
    Kulach, Natalia
    Czapla, Justyna
    Matuszczak, Sybilla
    Szala, Stanislaw
    ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2015, 63 (06) : 451 - 464
  • [9] Combined Tumor Cell-Based Vaccination and Interleukin-12 Gene Therapy Polarizes the Tumor Microenvironment in Mice
    Magdalena Jarosz-Biej
    Ryszard Smolarczyk
    Tomasz Cichoń
    Natalia Kułach
    Justyna Czapla
    Sybilla Matuszczak
    Stanisław Szala
    Archivum Immunologiae et Therapiae Experimentalis, 2015, 63 : 451 - 464
  • [10] Potentiation of immunologic responsiveness to dendritic cell-based tumor vaccines by recombinant interleukin-2
    Shimizu, K
    Fields, RC
    Redman, BG
    Giedlin, M
    Mulé, JJ
    CANCER JOURNAL FROM SCIENTIFIC AMERICAN, 2000, 6 : S67 - S75